Table 3.
Multivariable Associations of PBMC Subsets with the Outcome of Presence of Any CAC***
| Crude Models | Adjusted Models* | Extended Model** | Reduced Model | |||||
|---|---|---|---|---|---|---|---|---|
| OR | p | OR | p | OR | p | OR | p | |
| % CD4 CD8 (in CD3+) | 0.90 | 0.25 | 0.97 | 0.76 | ||||
| log % CD28 (in CD4+) | 1.45 | 0.033 | 1.15 | 0.52 | ||||
| square root % CD57 (in CD4 ) | 1.58 | 0.015 | 1.30 | 0.25 | ||||
| square root% CD57+ (in CD4+ CD56+) | 1.48 | 0.003 | 1.31 | 0.083 | 1.27 | 0.23 | 1.40 | 0.046 |
| square root % CD28 CD57+ (in CD4+) | 1.40 | 0.032 | 1.19 | 0.35 | ||||
| square root % HLA-DR+ (in CD4+) | 3.49 | 0.003 | 2.33 | 0.090 | 1.22 | 0.80 | ||
| square root % HLA-DR+ CD28 (in CD4+)+ | 2.25 | 0.018 | 1.50 | 0.31 | ||||
| log % CD28− (in CD8+) | 3.08 | 0.010 | 1.90 | 0.23 | ||||
| % CD57+ (in CD8+) | 1.76 | 0.002 | 1.37 | 0.17 | ||||
| %CD8+ CD56+that are CD57+ | 1.04 | 0.002 | 1.03 | 0.091 | 1.01 | 0.61 | ||
| % CD57+ in CD8+ CD56+) | 1.05 | 0.008 | 1.02 | 0.31 | ||||
| log % CD57+ in CD8+ CD56+) | 2.38 | 0.014 | 1.58 | 0.31 | ||||
| square root % HLA-DR+ (in CD8+) | 1.84 | 0.006 | 1.53 | 0.11 | 1.12 | 0.79 | ||
| square root% HLA-DR+ CD28− (in CD8+) | 1.43 | 0.055 | 1.41 | 0.19 | ||||
| %CD14hi CD16+ | 1.10 | 0.066 | 1.16 | 0.001 | 1.17 | 0.045 | 1.19 | 0.027 |
| %CD16+ | 1.07 | 0.035 | 1.12 | 0.023 | ||||
| %CD14hi CD16 | 0.95 | 0.079 | 0.96 | 0.25 | ||||
| square root all %CD3+ CD57+ | 1.68 | 0.001 | 1.34 | 0.14 | ||||
| log all %CD3 CD28 | 3.01 | 0.008 | 1.86 | 0.21 | ||||
| square root all %CD3+ HLA-DR+ | 1.89 | 0.003 | 1.56 | 0.081 | ||||
Adjusted Models are three covariate models containing the PBMC variable of interest, age, and SBP
The Extended Model contains all 5 PBMC variables listed in the same model, plus age and SBP
Abbreviations: PBMC Peripheral Blood Mononuclear Cells, CAC Coronary Artery Calcification.